The client was developing a proprietary fermentation platform based on genetically modified strains of Pseudomonas fluorescens capable of producing alginate. Since the core fermentation program was maintained as a trade secret, understanding the surrounding patent environment became essential before moving toward commercialization.
Alginate is a naturally occurring polysaccharide widely used due to its viscosity, gel-forming properties and biocompatibility. Its applications include food stabilizers and thickening agents, pharmaceutical formulations, biomedical materials and drug delivery systems.
The challenge was determining whether active third-party patent rights could restrict the client’s ability to manufacture alginate using engineered microbial strains. Earlier patent protections in the field had expired but related developments involving microbial engineering, alginate biosynthesis pathways and strain optimization required careful assessment.